Summary Targeting IR represents a promising translational approach for improving both metabolic and psychiatric outcomes in BD
GIP is interesting
Indian bodies show differences in beta-cell function and insulin response that are not fully explained by diet or lifestyle alone
This dual action reduces overall calorie intake and aids in weight loss
Separately, the TRANSCEND-T2D-1 trial part of a distinct diabetes programme rather than TRIUMPH reported an HbA1c reduction of up to 2.0 percentage points and 16.8 per cent weight loss at 40 weeks in 537 people with type 2 diabetes, and was published in The Lancet in June 2026
solvent used in the present invention can be selected from but not limited to hydrocarbon solvents such as n-pentane, n-hexane, n-heptane, cyclohexane, petroleum ether, benzene, toluene, xylene and the like